ArticleClinical genitourinary cancer2022

Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer.

Neal Andruska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.